eMedevents
  • 143,049+ Medical Conferences
  • 279 Specialties
  • 10,783 Organizers
  • 153,946 Speakers
  • 156 Countries
  • 4,640 Cities
47,683+
CME Conference Registrations Sold
Home  >  Speakers  >  Donald P. Mcdonnell
Donald P. Mcdonnell

Donald P. Mcdonnell

    PhD
Chairman, Professor | Durham, North Carolina    United States of America
Clinical Pharmacology
Clinical Pharmacology, Cell Biology,...More
Spoken at 1 event
Speaking at 1 event

Biography :

Donald McDonnell, PhD, is the Glaxo-Wellcome Professor of Molecular Cancer Biology in the Department of Pharmacology and Cancer Biology. In addition, he serves as the Associate Director for Basic Research for the Duke Cancer Institute.Dr. McDonnell obtained a Degree in Biochemistry from the National University of Ireland (Galway) in 1983. He then moved to Baylor College of Medicine, Houston, Texas, where in 1987, he obtained a PhD under the mentorship of Dr. Bert O’Malley.

It was during this time that he cloned the cDNA for the vitamin D receptor and performed a series of experiments that led to the conclusion that this receptor was related in both sequence and function to the classical steroid receptors. He subsequently spent a year as a postdoctoral fellow at Smith-Kline Pharmaceuticals in Philadelphia where he developed an interest in studying the molecular pharmacology of nuclear receptors. The development of mechanism-based screens for nuclear receptor agonists and antagonists was the focus of his research when he moved back to Baylor College of Medicine as an Assistant Professor of Cell Biology.

Given this interest in drug discovery, it was not a surprise that in 1991 he again returned to the private sector as Director and Head of Molecular Biology at Ligand Pharmaceuticals in San Diego. After three very exciting years in industry, he moved to Duke where his work has focused on the genetic and pharmacological dissection of the nuclear receptor signal transduction pathways. The insights from this work have led to the discovery and development of novel estrogen and androgen receptor modulators, some of which have advanced to the clinic and are being evaluated as treatments for a variety of endocrinopathies.

*************************
************
   
For speaker's contact information - Contact us

Specialties

Clinical Pharmacology

Interested Topics

Clinical Pharmacology, Cell Biology, Cancer Biology, Molecular Pharmacology, Drug Development, Immunohistochemistry, Biochemistry, Molecular Cancer Biology

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message